Company intelligence / Profile preview

Darou Pakhsh

Tehran, Iran

Ownership: Private
Employees: ~4440
Development stage: Commercial

Overview

Darou Pakhsh is the largest pharmaceutical company in Iran, producing and distributing over 300 medicines, including generics and specialty drugs, with no disclosed recent clinical trial data but a strong national and regional market presence.[1][2][3]

Therapeutic areas: Metabolic DisordersImmunologyNeurologyInfectious DiseasesOphthalmologyOncologyMen's HealthCardiovascularWomen's HealthEndocrinology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Biotest AG (plasmapheresis joint venture)

Beyond the preview

Go deeper on Darou Pakhsh.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Darou Pakhsh.

Explore the full profile